PCOS Clinical Trial - Comparison of Myoinositol & Metformin in PCO

Status Not yet recruiting

Clinical Trial Summary

Aim of the study is to compare the effect of myoinositol and metformin in the resumption of the spontaneous menstrual cycle in patients diagnosed with PCOS or having oligo/amenorrhea, reduction in weight and BMI, Improvement in the biochemical and clinical profile of patients with the polycystic syndrome. The secondary outcome measured will be the rate of pregnancy, miscarriage and term pregnancy among these patients inducted in the study. It will be a Three-arm prospective double-blind study. this clinical trial will be registered in Public registry. this RCT will be based on CONSORT statement. The patient coming to Gynecology OPD will be randomized into 3 groups GROUP A ( metformin 500 mg TDS), GROUP B( myoinositol 2mg x BD ), GROUP C.(both metformin,& myoinositol).each group will take folic acid and will be asked for lifestyle modifications.

Clinical Trial Description

PCOS is a common endocrine disorder in women of reproductive age associated with insulin resistance. Metformin and Myo-inositol being insulin sensitizers improve biochemical parameters. it is aimed to compare the effect of myoinositol and metformin in the resumption of the spontaneous menstrual cycle in patients diagnosed with PCOS or having oligo/amenorrhea, reduction in weight and BMI, Improvement in the biochemical and clinical profile of patients with the polycystic syndrome. Inclusion criteria: will be based on the Rotterdam criteria of diagnosing PCO. Patients presenting with a history of secondary amenorrhea, irregular menstrual cycle, oligomenorrhea, weight gain, hirsutism, and already diagnosed cases of PCO will be included in this group. Patients with history of Hyperprolactinemia, Cushing's disease, Hypothyroidism/ Hyperthyroidism, Pregnancy and nursing, Established type 1 or type 2 diabetes mellitus, Any history of drug intake e.g. anti-diabetic or estrogen and progesterone, History of treatment for the same complaint taken in the last 3 months, Unable to come for regular follow-ups, Any pathological cause of bleeding e.g. Fibroid, Polyp, Cervical pathology and known allergic to these drugs would be excluded. ;

Study Design

Related Conditions & MeSH terms

PCOS

Clinical Trial Details

NCT number	NCT04204044
Study type	Interventional
Source	Rashid Latif Medical College
Contact	LAMIA YUSUF, FCPS,MHPE
Phone	00923214549179
Email	doclamia@hotmail.com
Status	Not yet recruiting
Phase	Early Phase 1
Start date	November 1, 2020
Completion date	July 25, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06101147` - Effect of Vitamin D Supplementation on Testosterone Level in Women With Polycystic Ovary Syndrome	Phase 2
Completed	`NCT02037672` - PDE-4 Inhibitor Roflumilast and Polycystic Ovary Syndrome	Phase 4
Completed	`NCT01833949` - Unilateral Laparoscopic Diathermy Adjusted to Ovarian Volume	N/A
Completed	`NCT03608813` - Myo-inositol, D-chiro-inositol and Glucomannan in PCOS
Not yet recruiting	`NCT05298657` - The Angiotensin-Melatonin Axis in Poor and Hyper Responders for IVF Treatment
Completed	`NCT05951309` - Myoinositol Treatment and Asprosin Levels in PCOS	N/A
Enrolling by invitation	`NCT04485403` - The Effect of Ibuprofen on Women With PCOS.	Phase 2
Not yet recruiting	`NCT03978013` - Pomegranate Juice Effect on Oxidative Stress in Infertile Women During IVF Treatment	N/A
Recruiting	`NCT03767569` - Myo-inositol as Pretreatment in Hyperandrogenic PCOS Patients	Phase 3
Completed	`NCT05843955` - Non-alcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome
Recruiting	`NCT05971849` - Dampening the Reproductive Axis With Continuous Kisspeptin	Phase 1
Recruiting	`NCT04597099` - Androgen Blockade and Progesterone Augmentation of Gonadotropin Secretion	Early Phase 1
Active, not recruiting	`NCT05206448` - Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With Anovulation	Phase 4
Recruiting	`NCT02358421` - Prediction of High Ovarian Response After Assisted Reproductive Techniques	N/A
Completed	`NCT04113889` - Effects of Triple Drug Cocktail Therapy on Metabolic, Endocrine Alterations and Perceived Stress in Patients With Poly Cystic Ovary Syndrome	Phase 2
Completed	`NCT04562883` - Single vs. Group CAPA-IVM Culture of Cumulus-oocyte Complexes	N/A
Recruiting	`NCT03264638` - A Clinical and Biological Research of Combined Chinese and Western Medicine in the Treatment of PCOS	Phase 2
Completed	`NCT00594217` - Determining How Quickly Progesterone Slows LH Pulse Frequency	Phase 1
Recruiting	`NCT02024984` - Luteal Phase Versus Follicular Phase Administration of Clomiphene Citrate in PCOS, A Randomized Controlled Trial	Phase 1
Completed	`NCT01709942` - Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS)	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Comparison of Myoinositol and Metformin in PCO — PCO

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms